FAROPINOM DUO: A New Standard in Combating Resistant Infections.

May 13, 2024

FAROPINOM DUO

Faropenem 200mg and Potassium Clavulanate 125mg

FAROPINOM DUO combines the innovative effects of Faropenem 200mg and Potassium Clavulanate 125mg, developed by Steris Pharma to address the challenging problem of bacterial resistance. This combination enhances the antibiotic spectrum and efficacy, making it a formidable option against complex bacterial infections.

Synergy of Faropenem and Potassium Clavulanate

  • Faropenem: A carbapenem antibiotic known for its broad-spectrum activity against bacteria. It's effective against many antibiotic-resistant strains.
  • Potassium Clavulanate: Works as a beta-lactamase inhibitor, enhancing Faropenem's resistance to bacterial enzymes that typically degrade antibiotics.

Therapeutic Applications

  • Complicated UTIs and Respiratory Infections: Particularly effective where conventional antibiotics fail.
  • Skin and Soft Tissue Infections: Ideal for treating severe forms of infections like diabetic foot ulcers and major abscesses.
  • Sinusitis and Otitis Media: Provides robust treatment for infections in the sinus and ear regions.

Dosage and Administration

FAROPINOM DUO is typically prescribed based on the severity and location of the infection, with recommendations to take it twice daily. It should be taken with meals to maximize absorption and minimize potential gastrointestinal side effects.

Advantages of FAROPINOM DUO

  • Enhanced Effectiveness: Tackles resistant strains of bacteria, providing a more reliable treatment pathway.
  • Broad-Spectrum Activity: Addresses a wide range of infections, reducing the need for multiple medications.
  • Designed for Safety: Balances potent antibacterial effects with a focus on patient safety.

Conclusion

FAROPINOM DUO is an advanced formulation designed to meet the needs of today's challenging bacterial infections. Its dual-action approach not only curtails the spread of infection but also ensures that treatment is effective and comprehensive. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

SHARE WITH